Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA AJANTA PHARMA GLENMARK PHARMA/
AJANTA PHARMA
 
P/E (TTM) x -31.4 38.3 - View Chart
P/BV x 2.9 8.3 34.3% View Chart
Dividend Yield % 0.3 0.3 83.5%  

Financials

 GLENMARK PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
AJANTA PHARMA
Mar-23
GLENMARK PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4871,426 34.2%   
Low Rs3491,062 32.8%   
Sales per share (Unadj.) Rs460.4297.2 154.9%  
Earnings per share (Unadj.) Rs13.446.7 28.6%  
Cash flow per share (Unadj.) Rs35.057.1 61.4%  
Dividends per share (Unadj.) Rs2.507.00 35.7%  
Avg Dividend yield %0.60.6 106.3%  
Book value per share (Unadj.) Rs335.1269.1 124.6%  
Shares outstanding (eoy) m282.17125.91 224.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.94.2 21.7%   
Avg P/E ratio x31.326.6 117.3%  
P/CF ratio (eoy) x11.921.8 54.7%  
Price / Book Value ratio x1.24.6 27.0%  
Dividend payout %18.715.0 124.7%   
Avg Mkt Cap Rs m117,953156,638 75.3%   
No. of employees `000NANA-   
Total wages/salary Rs m27,8107,851 354.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,90137,426 347.1%  
Other income Rs m3,168986 321.2%   
Total revenues Rs m133,06938,413 346.4%   
Gross profit Rs m15,1257,833 193.1%  
Depreciation Rs m6,1131,308 467.3%   
Interest Rs m3,49658 5,986.0%   
Profit before tax Rs m8,6857,453 116.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,9111,573 312.2%   
Profit after tax Rs m3,7745,880 64.2%  
Gross profit margin %11.620.9 55.6%  
Effective tax rate %56.521.1 267.9%   
Net profit margin %2.915.7 18.5%  
BALANCE SHEET DATA
Current assets Rs m98,73728,252 349.5%   
Current liabilities Rs m50,45511,393 442.9%   
Net working cap to sales %37.245.0 82.5%  
Current ratio x2.02.5 78.9%  
Inventory Days Days766 10.2%  
Debtors Days Days11510 1,117.3%  
Net fixed assets Rs m76,92018,707 411.2%   
Share capital Rs m282253 111.7%   
"Free" reserves Rs m94,28133,624 280.4%   
Net worth Rs m94,56333,877 279.1%   
Long term debt Rs m38,52113 308,171.0%   
Total assets Rs m175,65847,047 373.4%  
Interest coverage x3.5128.6 2.7%   
Debt to equity ratio x0.40 110,399.9%  
Sales to assets ratio x0.70.8 93.0%   
Return on assets %4.112.6 32.8%  
Return on equity %4.017.4 23.0%  
Return on capital %9.222.2 41.3%  
Exports to sales %059.9 0.0%   
Imports to sales %011.5 0.0%   
Exports (fob) Rs mNA22,420 0.0%   
Imports (cif) Rs mNA4,293 0.0%   
Fx inflow Rs m46,46422,420 207.2%   
Fx outflow Rs m12,7124,293 296.1%   
Net fx Rs m33,75118,127 186.2%   
CASH FLOW
From Operations Rs m6,2547,918 79.0%  
From Investments Rs m-5,285-5,596 94.4%  
From Financial Activity Rs m-775-1,079 71.8%  
Net Cashflow Rs m3251,243 26.1%  

Share Holding

Indian Promoters % 46.7 66.2 70.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.7 25.8 134.5%  
FIIs % 23.7 9.1 260.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 33.8 157.9%  
Shareholders   209,931 54,351 386.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs AJANTA PHARMA Share Price Performance

Period Glenmark Pharma AJANTA PHARMA S&P BSE HEALTHCARE
1-Day -0.57% 2.51% 1.18%
1-Month 5.16% 7.60% -0.75%
1-Year 112.94% 92.91% 61.82%
3-Year CAGR 27.51% 21.63% 18.16%
5-Year CAGR 8.05% 26.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.